Furthermore, in the MI group, fib-GREM1 was observed to significantly interact with MHC-II+ cancer cells through the COL1A1-ITGA2 and IL24-IL20RB axes (Figure 9E), both of which are known to promote cancer cell stemness and support tumour aggressiveness. This evidence concerns the gene GREM1 and cancer.